Zoetis Expands Diagnostics with VitalRADS Acquisition
Event summary
- Zoetis to acquire VitalRADS, a veterinary teleradiology services platform, for undisclosed terms.
- Acquisition builds on an existing partnership announced in August 2025.
- VitalRADS offers around-the-clock access to board-certified specialists and AI-assisted report generation.
- Deal expected to close in Q3 2026, subject to regulatory approvals.
The big picture
Zoetis' acquisition of VitalRADS underscores a strategic push toward comprehensive end-to-end diagnostic solutions, combining specialist-led services with AI-driven efficiencies. This move aligns with broader industry trends toward digital transformation and data-driven veterinary care, positioning Zoetis to capture growth in high-margin diagnostics services.
What we're watching
- Integration Challenges
- How Zoetis will integrate VitalRADS' capabilities into its Global Diagnostics portfolio and ensure seamless transitions for existing customers.
- AI-Driven Growth
- The pace at which AI-assisted workflows from VitalRADS will enhance Zoetis' diagnostic offerings and drive productivity gains.
- Market Expansion
- Whether the acquisition will accelerate Zoetis' expansion into virtual reference lab services and strengthen its position in the veterinary diagnostics market.
Related topics